Design, Synthesis and Evaluation of New Antitumor Agents
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 5547
Special Issue Editor
Interests: medicinal chemistry; natural products total synthesis; asymmetric synthesis; bioactive natural products; polymeric materials; anticancer treatments; synthesis from biowaste-derived materials; isotopically labelled materials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In many countries around the world, cancer is the leading cause of death. This is particularly the case in developed countries which have an increasing average age of their populations. Despite great advances in its treatment, with numerous advances in chemotherapy, surgeries and radiation treatments, there are still many cancers which have poor patient prognosis and limited available therapies. There is therefore still a real need to develop new treatments for cancer, especially treatments with fewer side-effects than older classical treatments.
In this Special Issue, we wish to focus on all areas related to the development of new anti-tumour agents. This includes the discovery, design, synthesis and biological testing of novel treatments for cancer.
Prof. Dr. David Barker
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Drug design
- Anti-cancer
- Anti-neoplastic
- Anti-tumour
- Synthesis
- Natural products
- High throughput Screening
- Structural activity relationship (SAR)
- Biochemical assays
- Cell-based assays
- Drug delivery systems
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
